RCSI Crest - Staff Portal Version
Home » Uncategorized » Innovation Quarterly Workshop – December – GeneCell Bio

Innovation Quarterly Workshop – December – GeneCell Bio

GeneCell Bio Portal

Venue: VC Room, RCSI, 123 St Stephens Green, Dublin 2
Date & Time: Tuesday 13th December, 12:50 – 2pm

Light refreshments will be served from 12.55 – Speakers will begin at 1 pm sharp.

Please RSVP to innovation@rcsi.ie for catering purposes.

Speaker: Dr. Kieran Curran, Founder of GENECELL Bio

In this workshop, Kieran will share insights from his journey as a PhD student to Founder and CEO of an Irish state-of-the art DNA sequencing technology company, GeneCell Bio. This workshop will be of interest to post-graduates students, post-doctoral researchers and faculty members interested in the research commercialisation, entrepreneurship and career pathways outside academia.

About the Speaker:

Kieran’s doctoral studies at the University of Limerick focused on developing novel designs for micro-devices for use in medical diagnostics. Completing his Ph.D. in 2005, he joined an exciting UL start-up called Stokes Bio where he spent 3 years. As an inventor of the company’s core Liquid Bridge Technology, he participated in the design, development and commercialization of an innovative approach to genetic testing. Aged 25, Kieran founded his first company, Curran Scientific –  a specialist provider of engineering solutions. There, he led a team of engineers to provide design, test and manufacturing assistance to multi-national medical device companies. The desire for independent and novel technology development, however, never went away. In 2011, Kieran took the profits from Curran Scientific and invested them in a new venture called GenCell Biosystems. Over the next 4 years, Kieran led GenCell as CEO to develop best-in-class robotic genetic testing systems. With applications as broad as helping to improve human, animal and plant health – GenCell’s technology is helping researchers to explore the complexity of DNA at unprecedented speed and detail. In 2014, the performance of Gencell technology was noticed by Becton Dickinson and Company (BD), a global medical technology leader, who acquired the company for a reported €150M. Currently employing over 80 people at its Raheen facility, BD-GenCell is looking forward to a bright future in Ireland.

Seamus Browne PhD, MBA
Industry Liaison Manager


Page Author(s) -